Matches in Wikidata for { <http://www.wikidata.org/entity/Q64666519> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q64666519 description "clinical trial" @default.
- Q64666519 description "ensayu clínicu" @default.
- Q64666519 description "klinisch onderzoek" @default.
- Q64666519 description "клінічне випробування" @default.
- Q64666519 name "Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes" @default.
- Q64666519 type Item @default.
- Q64666519 label "Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes" @default.
- Q64666519 prefLabel "Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes" @default.
- Q64666519 P1050 Q64666519-EBD6B597-1685-4D9A-994E-8ECAEF812EF5 @default.
- Q64666519 P1132 Q64666519-0350298D-2867-471B-88E7-25CBBDC9A456 @default.
- Q64666519 P1476 Q64666519-E8AC2017-729A-4D7C-B457-EABC99184F44 @default.
- Q64666519 P17 Q64666519-06926C01-5ED1-43F0-AFA3-E898787F9DB0 @default.
- Q64666519 P17 Q64666519-264A8475-9EDA-471C-8378-DF409C8B3DF8 @default.
- Q64666519 P17 Q64666519-2BC48958-6EA9-4480-8440-A546380473D0 @default.
- Q64666519 P17 Q64666519-2F1D6C51-B9C2-47CC-B571-1FE8F2775D96 @default.
- Q64666519 P17 Q64666519-3EE926FB-4338-4C6B-AA4D-DCED8BAC46D6 @default.
- Q64666519 P17 Q64666519-758E7C98-C40F-459E-B920-52D00D259388 @default.
- Q64666519 P17 Q64666519-9E9284E1-190E-42C9-8970-26D70E8EABDA @default.
- Q64666519 P17 Q64666519-D9FFDABA-B98E-45C6-8386-2DB10F871DB0 @default.
- Q64666519 P17 Q64666519-EF0E5FD1-5AA3-48BA-B3EE-7CD1A2D8D483 @default.
- Q64666519 P17 Q64666519-F4E115EE-7B7F-40BC-B7EF-1A0FFDB8CA7A @default.
- Q64666519 P1813 Q64666519-402EC8FA-B8DD-430A-9C32-0F5F06E039C9 @default.
- Q64666519 P2899 Q64666519-A855358E-EE34-4CA9-9C2B-54458DC1E4EB @default.
- Q64666519 P3098 Q64666519-BFFE96F7-2FF2-41E6-89F2-A0D666DC8100 @default.
- Q64666519 P31 Q64666519-0B0C57DF-6145-47E1-9A2A-3791FEDA18CC @default.
- Q64666519 P4844 Q64666519-56848F02-1701-4AA1-9D26-232CF2A39850 @default.
- Q64666519 P4844 Q64666519-E9D92105-4929-4FEB-98FE-F3B05D028D7A @default.
- Q64666519 P580 Q64666519-200DB91F-245B-4440-AFA8-4E83A087C3CE @default.
- Q64666519 P582 Q64666519-F2E12E0C-B810-4114-9617-AEDDC6E9B9E2 @default.
- Q64666519 P6099 Q64666519-9E425BC5-E6FC-4D1A-93CD-E457EAFF2F47 @default.
- Q64666519 P6153 Q64666519-9DB4E06F-6AD5-4251-92E2-49D28B51C828 @default.
- Q64666519 P8363 Q64666519-7EE5221D-BEE5-4F09-8F4C-A6EB1777C598 @default.
- Q64666519 P1050 Q12206 @default.
- Q64666519 P1132 "+447" @default.
- Q64666519 P1476 "A 26-week, Randomised, Open-labelled, Two-arm, Parallel-group, Treat-to-target Trial Comparing Efficacy and Safety of Soluble Insulin Analogue Combination (SIAC) Twice Daily (BID) With Biphasic Insulin Aspart (BIAsp) 30 BID, With or Without Metformin, With or Without DPP-4 Inhibitor, With or Without Pioglitazone in Subjects With Type 2 Diabetes in Inadequate Glycaemic Control on Once or Twice Daily Premixed or Self-mixed Insulin Regimen With or Without OADs (BOOST™: Intensify Premix 1)" @default.
- Q64666519 P17 Q33 @default.
- Q64666519 P17 Q34 @default.
- Q64666519 P17 Q35 @default.
- Q64666519 P17 Q36 @default.
- Q64666519 P17 Q408 @default.
- Q64666519 P17 Q43 @default.
- Q64666519 P17 Q668 @default.
- Q64666519 P17 Q833 @default.
- Q64666519 P17 Q865 @default.
- Q64666519 P17 Q869 @default.
- Q64666519 P1813 "BOOST™" @default.
- Q64666519 P2899 "+18" @default.
- Q64666519 P3098 "NCT01009580" @default.
- Q64666519 P31 Q30612 @default.
- Q64666519 P4844 Q1929845 @default.
- Q64666519 P4844 Q19484 @default.
- Q64666519 P580 "2009-11-05T00:00:00Z" @default.
- Q64666519 P582 "2010-08-23T00:00:00Z" @default.
- Q64666519 P6099 Q42824827 @default.
- Q64666519 P6153 Q818846 @default.
- Q64666519 P8363 Q78089383 @default.